Podcasts about opioids

Popp Talk with Mary Jane Popp Biotech Breakthroughs, Hidden Pain, and the Truth We Struggle to Tell Guests, Tim Harris and Michelle May A Potpourri of Health, Science, and Self-Understanding In this episode of Popp Talk, host Mary Jane Popp introduces a wide-ranging “potpourri” show covering biotechnology, health, therapy, and the hidden struggles people sometimes carry beneath the surface. She begins by setting up an interview with Tim Harris, author of In Pursuit of Unicorns: A Journey Through 50 Years of Biotechnology, and later introduces Michelle May, psychotherapist and author of What I Couldn't Tell My Therapist. The episode moves from the evolution of biotech and medical innovation to emotional repression, chronic pain, social media misinformation, and the importance of personal responsibility. Tim Harris on Biotechnology and the Pursuit of Unicorns Mary Jane's first guest, Tim Harris, defines biotechnology as the combination of biology and technology, beginning with recombinant DNA and monoclonal antibodies. He explains that his book title uses the word “unicorns” because biotech companies can become billion-dollar enterprises, though some valuations may prove more mythical than real. Harris presents biotechnology not only as a scientific field but also as a business story shaped by companies, capital, invention, risk, and the long effort to turn scientific tools into useful products. Recombinant DNA, Monoclonal Antibodies, and Gene Editing Harris walks listeners through the development of recombinant DNA, explaining how scientists learned to combine pieces of DNA and use bacteria such as E. coli to produce important proteins like insulin and growth hormone. He also explains monoclonal antibodies as single antibodies made by cloned cells, first useful for diagnostics and later for therapies. The conversation then turns to gene editing, including CRISPR-Cas9 and its use in sickle cell disease, which Harris describes as life-changing for patients whose lives revolve around managing pain and disease. Cancer, mRNA Vaccines, AI, and the Risks of Innovation Mary Jane and Harris discuss why cancer remains difficult to treat, with Harris explaining CAR T-cell therapy, its success in certain leukemias and lymphomas, and the continuing challenge of solid tumors such as breast, prostate, and colon cancer. He also connects nanotechnology to COVID-19 mRNA vaccines, describing lipid nanoparticles as the delivery system for messenger RNA. The conversation expands into new COVID strains, vaccine updates, artificial intelligence, risk assessment, and the limits of prediction in biology. Harris emphasizes that while AI can help analyze data and predict viral changes, drug discovery and development remain experimental sciences. Michelle May's Story of Chronic Pain and Repressed Emotion The second major interview features Michelle May, who shares that she woke up in 2007 with a headache that lasted six years. Doctors eventually found a Chiari malformation, and after two brain surgeries, her head pain improved dramatically. Still, some headaches remained, and May says she later learned through intensive dynamic therapy that repressed emotions also contributed to her pain. She explains that anger, grief, guilt, and love can be pushed out of awareness when people grow up in environments where certain feelings do not feel safe, but those emotions may still remain in the body. What People Cannot Tell Their Therapist May explains that the title What I Couldn't Tell My Therapist has two meanings: the painful family stories she feared would feel like betrayal, and the truths she had not yet admitted to herself. She describes how patients may minimize or filter their experiences, especially when they love the people who hurt them. Mary Jane presses her on how therapy helps uncover those hidden barriers, and May explains that she watches for avoidance patterns, such as looking away, intellectualizing, minimizing pain, or struggling to stay connected while discussing intimacy and emotion. Pain, Anxiety, Opioids, Social Media, and Responsibility The interview broadens into the overlap between physical pain and emotional pain, with May stressing that medical causes should always be ruled out first before exploring emotional processes. She distinguishes between feelings and actions, explaining that anger is a bodily experience while harmful behavior is a choice. The conversation also covers chronic pain, opioid dependence, the mind-body connection, social media misinformation, fact-checking, political and cultural falsehoods, and the difficulty people have admitting they were wrong. The episode closes with May encouraging people to find a therapist they trust, while Mary Jane emphasizes comfort, accountability, and the need to stop blaming others when personal responsibility is required.

Singer Melissa Etheridge talks about touring with Wynonna Judd and the inspiration behind her new album “Rise.”

Come with Brandon down the rabbit hole and learn how the opioid crisis got so bad and who was at fault

In this episode of Denatured, you'll hear from Lance Alstodt, chairman and CEO at Biorestorative Therapies, and Paul Mieyal, chief business officer at South Rampart Pharma. We explore why pain has remained such a difficult therapeutic area to tackle and one of the biggest unmet needs today, and how non-opioid mechanisms to regenerative therapies could reshape the future of treatment.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsLance Alstodt, Chairman & CEO, BioRestorative TherapiesPaul Mieyal, Chief Business Officer, South Rampart PharmaDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

In this episode of The President's Daily Brief: The battle for the Strait of Hormuz is entering a dangerous new chapter. We examine why the Trump administration has once again shifted its strategy against Iran—and what that tells us about where the war is headed. The remnants of Russia's Wagner mercenary force have reportedly traded the battlefield for the drug trade. We look at allegations that former Wagner fighters are operating a growing opioid empire in one of Africa's most lawless regions. The Trump administration launches a new campaign against the International Criminal Court, with Secretary of State Marco Rubio vowing to curb the tribunal's influence and shield Americans from its jurisdiction. In today's Back of the Brief, Congress moves to honor the late Senator Lindsey Graham by reviving one of his signature priorities: a sweeping new package of sanctions targeting Russia. To listen to the show ad-free, become a premium member of The President's Daily Brief by visiting https://PDBPremium.com. Please remember to subscribe if you enjoyed this episode of The President's Daily Brief.  YouTube: youtube.com/@presidentsdailybrief Lifepro Fitness: Discover how to beat puffiness with the Lifepro Waver Vibration Plate—and use code PDB at https://lifeprofitness.com for $20 off plus free shipping! Mars Men: For a limited time, our listeners get 50% off FOR LIFE, Free Shipping, AND 3 Free Gifts at Mars Men at https://Mengotomars.com Ridge: One thing to pack, five ways to power! Get 10% off @Ridge with code PDB at https://www.Ridge.com/PDB#Ridgepod Learn more about your ad choices. Visit megaphone.fm/adchoices

I sat down with Dr. Andrea Sereda at the Sherbourne Health Centre on the east side of downtown Toronto, an area of the city sometimes known for its challenges with drug abuse. Who is Dr. Andrea Sereda? She is a family physician who practices street outreach medicine and provides care through the London InterCommunity Health Centre in London, Ontario. She works with the emergency safer supply substitution program, prescribing hydromorphone, an opioid used by injection drug users to reduce the risk of contaminated street drugs. Wait! What? Yes, on the face of it, Dr. Andrea Sereda gives drugs to drug users but there is a lot more to the story. We are going right to the front lines of the opioid epidemic which, even before the end of this conversation, will take 10 lives in North America alone. (To illustrate the issue more deeply, 8,048 Americans died of opioid related drug overdoses in 1999. What about now? Well, the number was approximately 70,000 drug overdose deaths last year.) It will take ingenuity, creativity, and passion to address this issue. As you'll hear, Dr. Andrea Sereda offers all three in spades. Her views are often provocative, sometimes controversial, and she will argue that drugs should be decriminalized and why we should indeed give drugs to drug users. What about the challenges to these ideas? The critics? The controversies? We get into that, too. And we are fortunate enough to use Andrea's three most formative books as a launchpad into this conversation. I am so grateful to Dr. Andrea Sereda for sharing so much of her life, her journey, and her practice with all of us. I find her and her work incredibly challenging, intriguing, and inspiring. I hope you do, too.

At the Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine (FPM) held in Auckland, New Zealand, Kate Leslie and Andy Cumpstey interview Neel Desai about non-opioid multi-modal analgesia, especially the use of paracetamol/NSAID combinations for minor surgery. Dr Neel Desai is a Consultant Anaesthetist at Guys and St Thomas's Hospital, London, UK. He is supported by AFT Pharmaceuticals. -- The 2026 International Practicum on Cardiopulmonary Exercise Testing will be held at the Balmer Lawn Hotel in Brockenhurst, UK, from September 16th to 18th this year. It is organised by iPOETTS , the international perioperative testing and training society. Come and join us at this premier educational event designed for clinicians, scientists, and healthcare professionals interested in sport, exercise, and perioperative medicine. This is an International Perioperative Testing and Training Society accredited event so when you attend you can get your iPOETTS accreditation, showing that you are a practitioner who has reached a high, standardized level of competence in performing and interpreting Cardiopulmonary Exercise Testing (CPET) for patients preparing for major surgery. Go now to http://www.ebpom.org

The price of household goods is up again, Wawa loses a legend, and Albertsons' opioid trial has begun.

A special program sends nurses who contract with the city to businesses including stores, restaurants, gas stations, barbershops and banks to train workers on how to use the overdose-reversal drug naloxone.

Gov. Beshear asks for more information on Sen. McConnell's health, McConnell's wife releases a statement about her trip to China days after her husband was hospitalized, candidates for Kentucky's Sixth Congressional District participate in their first candidate forum, and Kentucky launches a dashboard to track how counties and cities are using opioid settlement dollars.

Fifty years ago the U.S. government classified it alongside heroin: no accepted medical use, high potential for abuse, illegal in most of the world. The peer-reviewed data now coming out of Johns Hopkins, Imperial College, and Nature tells a different story, one that has some of the most credentialled neuroscientists alive rethinking how the brain heals. In this episode, Louisa breaks down exactly what psilocybin does to your neurons, why it works where antidepressants stall for decades, and where the research is heading right now. She walks through the default mode network, the self-referential system that turns rigid and hyperactive in depression, and the 2024 Nature study that described psilocybin's effect on it as "massive" disruption. You'll hear how a single dose drove a measurable jump in dendritic spine density within 24 hours, why psilocin binds the TRKB receptor 300 times more strongly than any conventional antidepressant, and how Robin Carhart-Harris's head-to-head trial against escitalopram produced more than double the remission rate. Then she turns to addiction, where psilocybin-assisted therapy reached an 80% smoking abstinence rate at six months in the Johns Hopkins pilot, more than double the best medication available today. She covers the risks the drug-war narrative leaves out, the hard contraindications around psychosis and cardiac history, the April 2026 executive order that accelerated federal review, and why the quality of the subjective experience, measured on the Mystical Experience Questionnaire, may matter to the outcome as much as the molecule itself. You'll also hear about the desynchronization event and what fills the space when the network goes offline, BDNF and how it stacks up against high-intensity exercise, the alcohol and opioid data, HPPD, Australia's 2023 reclassification, Oregon and Colorado's state access frameworks, and why set and setting may be active ingredients in how the treatment works. Fifty years ago the U.S. government classified it alongside heroin: no accepted medical use, high potential for abuse, illegal in most of the world. The peer-reviewed data now coming out of Johns Hopkins, Imperial College, and Nature tells a different story, one that has some of the most credentialled neuroscientists alive rethinking how the brain heals. In this episode, Louisa breaks down exactly what psilocybin does to your neurons, why it works where antidepressants stall for decades, and where the research is heading right now. She walks through the default mode network, the self-referential system that turns rigid and hyperactive in depression, and the 2024 Nature study that described psilocybin's effect on it as "massive" disruption. You'll hear how a single dose drove a measurable jump in dendritic spine density within 24 hours, why psilocin binds the TRKB receptor 300 times more strongly than any conventional antidepressant, and how Robin Carhart-Harris's head-to-head trial against escitalopram produced more than double the remission rate. Then she turns to addiction, where psilocybin-assisted therapy reached an 80% smoking abstinence rate at six months in the Johns Hopkins pilot, more than double the best medication available today. She covers the risks the drug-war narrative leaves out, the hard contraindications around psychosis and cardiac history, the April 2026 executive order that accelerated federal review, and why the quality of the subjective experience, measured on the Mystical Experience Questionnaire, may matter to the outcome as much as the molecule itself. You'll also hear about the desynchronization event and what fills the space when the network goes offline, BDNF and how it stacks up against high-intensity exercise, the alcohol and opioid data, HPPD, Australia's 2023 reclassification, Oregon and Colorado's state access frameworks, and why set and setting may be active ingredients in how the treatment works. *Reduce your risk of Alzheimer's with my science-backed protocol for women 30+: * https://go.neuroathletics.com.au/youtube-sales-page Subscribe to The Neuro Experience for evidence-based conversations at the intersection of brain science, longevity, and performance. _____ *TOPICS DISCUSSED* 00:00 Intro: A Schedule I Drug That's Making Neuroscientists Rethink the Brain 00:39 The Default Mode Network and Your Sense of Self 02:49 How Depression Locks the Brain Into a Rigid Loop 03:23 Where SSRIs Stop Short of the Problem 04:44 The Brain Imaging Data: "Massive" DMN Disruption and Reorganization 06:58 Confirming It in Drug-Naive Brains 08:04 The Rewiring: How Psilocybin Changes Neural Architecture 08:35 Dendritic Spines and Synaptic Density 09:39 How Chronic Stress Shrinks Your Neural Connections 10:16 One Dose, More Connections in 24 Hours (Neuron 2021) 11:02 BDNF, TRKB, and a Signal 300x Stronger Than Antidepressants 13:21 Psilocybin vs the Gold-Standard SSRI 14:37 Double the Remission Rate: The Numbers That Matter 15:53 Side Effects, Durability, and Treatment-Resistant Depression 16:39 The Addiction Breaker: 80% Smoking Abstinence at Six Months 17:36 Alcohol, Opioids, and the Shared Architecture of Addiction 19:10 The Dark Side: Real Risks and Hard Contraindications 22:35 The Policy Earthquake: Executive Orders and FDA Breakthrough Status 24:37 Why It Actually Works: Set, Setting, and the Mystical Experience 26:57 Bringing It All Together _______ *Thank you to our sponsors* Function Health: https://functionhealth.com/LouisaNicola Use code NEURO25 for a $25 credit BASED Bodyworks: https://basedbodyworks.com/ Use code NEURO for 20% off (plus a free toiletry bag with any set) BioOptimizers: https://www.bioptimizers.com/neuro Use code NEURO for 15% off IQBAR: Text NEURO to 64000 for 20% off all IQBAR products plus FREE shipping (Message and data rates may apply) Learn more about your ad choices. Visit megaphone.fm/adchoices

Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial JAMA Network Open This randomized clinical trial of 340 adults with opioid use disorder (OUD) taking buprenorphine examined the comparative effectiveness of 2 psychosocial treatments—cognitive- behavioral therapy (CBT) and peer recovery support (PRS)—on opioid abstinence when used as adjunctive therapy to office-based buprenorphine treatment in adults with OUD.  Researchers found that neither PRS, CBT, nor a combination of these psychosocial interventions yielded differential effects on opioid abstinence. These results suggest that adjunctive psychosocial interventions may not enhance buprenorphine treatment outcomes in the early stages of treatment.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

My friend Ryan Rogers returns to the podcast for our third conversation. He's an addictions counselor in Texas, host of Reality Therapy, and now the author of two books — The Woke Mind and his new release, The Carpenter's Recovery, a Christian guide to 12-step recovery. We start with what's being called "gas station heroin": a chemical called 7-OH, extracted from kratom, that's roughly thirteen times stronger than morphine and sold legally next to the 5-Hour Energy drinks at the checkout counter. Ryan walks me through how legal loopholes have produced a generation of accidental addicts, including church kids and high-conscientiousness adults who'd never touch illegal drugs. I share my own "little old lady" story — how my elderly mom was given a 10mg THC gummy by her stoner massage therapist — as a warning to anyone navigating this new landscape with vulnerable elders. From there we go into cannabis-induced psychosis, cannabis use hyperemesis disorder, fentanyl displacing heroin, and what's actually working in addiction treatment. Ryan explains why he wrote a Christian recovery book and why naming Jesus in AA meetings still gets people shut down. We close on the state of the therapy field: woke ideology, AI psychosis, the rise of niche experts over licensed therapists, and why "live your truth, king" is the worst possible response to a client telling you they're about to relapse.Follow Reality Therapy podcast | Follow Ryan on X @ryanmcrogers[00:00:00] Start[00:02:06] Gas Station Heroin: What Is 7-OH?[00:05:55] Kava, Feel Free, and Designer Drugs[00:11:25] How 7-OH Hits the Opioid System[00:14:30] The Little Old Lady THC Gummy Story[00:25:30] Methadone vs. Suboxone for Detox[00:35:56] The Carpenter's Recovery: A Christian Approach[00:40:32] Why AA Pushes Back on Christianity[00:48:15] Reality Therapy and the State of the Field[00:53:42] AI Psychosis and the Future of Therapy[00:58:40] Tough Love and "Live Your Truth, King"[01:04:30] Honoring Who Teenagers Are BecomingROGD REPAIR Course + Community gives concerned parents instant access to over 120 lessons providing the psychological insights and communication tools you need to get through to your kid. Now featuring 24/7 personalized AI support implementing the tools with RepairBot! Use code SOMETHERAPIST2026 to take 50% off your first month.PODCOURSES: use code SOMETHERAPIST at LisaMustard.com/PodCoursesPRODUCTION: Looking for your own podcast producer? Visit PodsByNick.com and mention my podcast for 20% off your initial services.MUSIC: Thanks to Joey Pecoraro for our song, “Half Awake,” used with gratitude & permission.ALL OTHER LINKS HERE. To support this show, please leave a rating & review on Apple, Spotify, or wherever you get your podcasts. Subscribe, like, comment & share via my YouTube channel. Or recommend this to a friend!Learn more about Do No Harm.Take $200 off your EightSleep Pod Pro Cover with code SOMETHERAPIST at EightSleep.com.Take 20% off all superfood beverages with code SOMETHERAPIST at Organifi.Check out my shop for book recommendations + wellness products.Show notes & transcript provided with the help of SwellAI.Special thanks to Joey Pecoraro for our theme song, “Half Awake,” used with gratitude and permission.Watch NO WAY BACK: The Reality of Gender-Affirming Care (our medical ethics documentary, formerly known as Affirmation Generation). Stream the film or purchase a DVD. Use code SOMETHERAPIST to take 20% off your order. Follow us on X @2022affirmation or Instagram at @affirmationgeneration.Have a question for me? Looking to go deeper and discuss these ideas with other listeners? Join my Locals community! Members get to ask questions I will respond to in exclusive, members-only livestreams, post questions for upcoming guests to answer, plus other perks TBD. ★ Support this podcast on Patreon ★

On this podcast episode, I cover commonly used medications for opioid use disorder. Buprenorphine, methadone, and naltrexone are all potential options in OUD. I’ll discuss the pharmacology of each medication and the most common practice pearls that will show up in practice and on your board exams. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101

Interview with Willie Eggleston, PharmD

Dr. Sterling Elliott talks about where we are with the ongoing opioid crisis, pain management, and available unregulated pseudo-pharmaceutical combinations available in smoke shops and gas stations. Dr. Elliott is the Clinical Pharmacist Lead for Ambulatory Surgery Practice at Northwestern Memorial Hospital (NMH) in Chicago, Illinois. He specializes in matters related to post-operative pain management in ambulatory surgeries. Dr. Elliott's expertise on patient-centered pain management education and harm reduction efforts has been featured on numerous Chicago, as well as national print, radio, and television outlets. Dr. Elliott speaks at conferences, including keynote sessions, sharing his expertise in pain management, the American opioid epidemic, and harm reduction with Narcan®. View Dr. Elliott's faculty profile. The State of Wisconsin's Dose of Reality campaign is at Dose of Reality: Opioids in Wisconsin. More information about the federal response to the ongoing opiate crisis can be found at One Pill Can Kill. The views and opinions of the guests on this podcast are theirs and theirs alone and do not necessarily represent those of the host or Westwords Consulting. We're always interested in hearing from individuals or organizations who are working in substance use disorder treatment or prevention, mental health care and other spaces that lift up communities. This includes people living those experiences. If you or someone you know has a story to share or an interesting approach to care, contact us today! Follow us on Facebook, LinkedIn, and YouTube. Subscribe to Our Email List to get new episodes in your inbox every week!

“Opioid-sparing” sounds like an automatic win until you look closely at what replaces the opioids. We take on one of the toughest questions in modern anesthesiology: how do we reduce opioid-related harm without trading it for medication interactions, kidney injury, bleeding risk, rebound pain, or poorly controlled postoperative pain?We break down what individualized multimodal analgesia really means in day-to-day anesthesia practice. That starts before the first dose is ordered, with a preoperative assessment that weighs comorbidities, baseline renal function, hydration status, and potential drug-drug interactions. We also dig into the medication safety side of multimodal protocols, including why CYP2D6 matters for common oral opioids like hydrocodone, oxycodone, and tramadol, and how CYP2D6 inhibitors such as certain antidepressants can change opioid effectiveness and even extend opioid use after discharge.Regional anesthesia remains a cornerstone, but we stay honest about the pitfalls: incomplete coverage, visceral pain that sneaks through, and the timing mismatch that can trigger rebound pain 12 to 24 hours after a single-shot block, sometimes when the patient is already home. We also discuss when continuous peripheral nerve blocks may better match the duration of perioperative stress and inflammation, plus the practical barriers that determine whether advanced regional techniques are feasible.If you care about opioid-sparing anesthesia, patient safety, and better postoperative recovery, listen and share this with a colleague. Subscribe to the podcast, leave a review, and tell us: what's one change you'll make to your multimodal analgesia plan after hearing this?For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/313-individualized-multimodal-analgesia/© 2026, The Anesthesia Patient Safety Foundation

In this wild, unpredictable hour, host Walter Sterling and UFO expert Dave Scott dive deep into the government's alleged UFO crash retrieval programs, top-secret 25-story underground bunkers, and why private corporations might be hiding alien bodies to dodge Freedom of Information Act requests. Walter brings you the "real" news. Cap it all off with bizarre listener UFO sightings and a caller who masterfully connects opioids, Obama, and COVID cremations into one glorious conspiracy theory. Buckle up and embrace the other side! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Thomas K Varghese, Jr, MD, FACS, is joined by Serena Lofftus, MD, and James Wu, MD, FACS, from UCLA. They discuss Drs Lofftus and Wu's recent article, “Patient-Based Decision Making for Opioid Prescriptions After Ambulatory Breast Operation: A Randomized Clinical Trial,” which evaluated whether incorporating patient choice into postoperative prescribing decisions could reduce opioid prescribing and consumption after ambulatory breast operation without negatively affecting pain control or quality of life.   Disclosure Information: Drs Varghese, Lofftus, and Wu have no relevant financial conflicts of interest to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Lofftus, Serena Y MD1,4; Graham, Danielle S MD, PhD1,4; Le, Julie MD, FACS1,2; Zhu, Catherine Y MD1,3; Kaufman, Noy MD4,5; Huy, Tess C MD1,4; Kusske, Amy M MD, FACS1,4; Teshome, Mediget MD, FACS1,4; Baker, Jennifer L MD, FACS1,4; Wu, James X MD, FACS4,6. Patient-Based Decision Making for Opioid Prescriptions After Ambulatory Breast Operation: A Randomized Clinical Trial. Journal of the American College of Surgeons ():10.1097/XCS.0000000000001974, April 13, 2026. | DOI: 10.1097/XCS.0000000000001974   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

John Prinz shares his story of replacing 1,100 mg/day OxyContin with medical cannabis, positioning him as an early "patient zero" in opioid-to-cannabis transition. A 1992 workplace injury at Simpson Paper in Anderson, CA led to five spinal surgeries, hardware implantation, and a spinal cord injury diagnosis, setting the foundation for extreme opioid dependency. At peak dosage around 2004–2005, John was prescribed over 1,100 mg of OxyContin daily alongside 13 other medications — far exceeding the typical 20–40 mg average — before the opioid epidemic was officially recognized. Dr. Lester Grinspoon's book "Marijuana, the Forbidden Medicine" was the turning point, leading John to recognize opioids as legal heroin and motivating his decision to pursue cannabis as a replacement. Transition off opioids took approximately 18 months of withdrawal, during which John developed his cannabis olive oil formula "Fusatima" — progressing from smoking to edibles to concentrated olive oil infusions. Fusatima is made with 3 liters of Costco olive oil and 1 lb of high-quality cannabis, slow-cooked at 180°F; one tablespoon yields ~300 mg combined THCA/THC, with a full dose of 4 tablespoons twice daily reaching ~2,400 mg. Lower heat during preparation preserves more THCA (non-psychoactive), while higher heat converts it to THC — allowing dosage customization depending on whether patients want psychoactive effects. THCA capsules made from raw, unheated cannabis are recommended for patients who want pain relief without the high, broadening the formula's accessibility. Post-surgery use at UCSF in June 2025 demonstrated Fusatima's clinical viability — John used no opioids after his sixth back surgery, self-administering the formula four days post-op with his surgeon's awareness. John's pain doctor Dr. Michael H. Moskowitz documented cannabis use in monthly medical records from 2005 to 2021, and those papers have since been used to educate other patients and gain acceptance from Medicare and Social Security. Advocacy efforts included writing Senator Dianne Feinstein starting in 2009, which John credits as contributing to OxyContin's removal from the market by 2011–2015, and writing Senator Obama in 2007 requesting rescheduling. Fentanyl's rise on the streets is directly linked to forced opioid withdrawal — patients lost prescriptions without a sanctioned alternative, and cannabis remains underutilized due to stigma even among marijuana advocates. Trump's executive order rescheduling cannabis to Schedule III is seen as a pivotal moment, though pharmaceutical companies including Jazz Pharmaceutical (105 patents), Pfizer (25), and Bristol-Myers Squibb (36) are positioned to commercialize it. Getting Fusatima into pharmacies — regardless of who manufactures it, including potentially a Sackler-backed company — is the stated goal, as insurance reimbursement only becomes possible once it reaches the pharmacy system. Core takeaway: growing your own cannabis is the most reliable path to access and affordability — patients who don't grow will struggle to maintain supply, and self-sufficiency is framed as the foundation of medical freedom. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dan is joined by Brian Wilson to talk a variety of topics, and then covers a national story that touches Tennessee as a doctor is arrested for medical fraud, having prescribed hundreds of thousands of pills | aired on Wednesday, June 24th, 2026 on Nashville's Morning News with Dan Mandis Produced by Samuel RutherfordSee omnystudio.com/listener for privacy information.

Hampton Roads communities are using new opioid settlement funds to address gaps that local officials say go beyond treatment beds.

It's the Pipeman – The Wandering Jew spinoff of The Adventures of Pipeman.Today we bring on Dave Aronberg a hero of truth and justice in the Opioid Epidemic and the current state of Antisemitism in the world.Dave Aronberg served three terms as the elected State Attorney for Palm Beach County from 2012 to 2024, where he led a team of 115 prosecutors and 180 professional staff in five offices throughout Palm Beach County. He is also a former Assistant Attorney General, White House Fellow and Florida Senator.In 2016, Aronberg created a Sober Homes Task Force that made more than 120 arrests for patient brokering and insurance fraud in the rehab industry, and has led to several new Florida laws and regulations that have become the model for other states. Aronberg's efforts also convinced Google to restrict advertisements and improve screening for addiction treatment. The crackdown in rogue sober homes and corrupted drug treatment centers contributed to a dramatic decrease in opioid-caused deaths in Palm Beach County.Dave Aronberg was born in Miami. He attended public schools before going on to graduate with honors from Harvard College and Harvard Law School. After graduation, he worked in the litigation department of a large South Florida law firm while also working closely with Insurance Commissioner Bill Nelson to investigate European insurance companies that refused to honor World War II-era policies sold to victims of the Holocaust.In 2000, Aronberg was selected to be one of 15 White House Fellows from across the country. In this nonpartisan position, he served in two presidential administrations as a Special Assistant to the Secretary of the Treasury Department for international money laundering, including the laundering of terrorist assets.Dave Aronberg was elected to the State Senate in 2002 as its youngest member and served until 2010. In 2010, Aronberg returned to the Florida Attorney General's Office as a Special Prosecutor for Prescription Drug Trafficking. In his role as the Attorney General's “Drug Czar,” Aronberg led an anti-pill mill initiative that helped clean up the pain clinic industry and reduced the record number of people dying each day from oxycodone abuse.Aronberg is a trial skills instructor at Harvard Law School, and frequently appears on cable television as a legal commentator. He is the managing partner of Dave Aronberg Law, P.A., and a strategic partner with Capital City Consulting in West Palm Beach. Pipeman – The Wandering Jew is a spin-off podcast born of The Adventures of Pipeman. The show is The Movement of An Avenger for Jews Everywhere Fighting Antisemitism & Hate Globally. It's Not Just a Podcast! It's a Jewish Movement of Love & Unity For All of Humanity with guests of all religions in support of Jews and even guests who are Antisemites to debate the TRUTH!Click Here to Subscribe to The Adventures of Pipeman for PERKS, BONUS Content & FREE GIVEWAYS! Take some zany and serious journeys with The Pipeman aka Dean K. Piper, CST on The Adventures of Pipeman also known as Pipeman Radio syndicated globally “Where Who Knows And Anything Goes.”   Would you like to be a sponsor of the show?Would you like to have your business, products, services, merch, programs, books, music or any other professional or artistic endeavors promoted on the show?Would you like to be interviewed as a professional or music guest on The Adventures of Pipeman, Positively Pipeman and/or Pipeman in the Pit?Would you like to host your own Radio Show, Streaming TV Show, or Podcast?  PipemanRadio Podcasts are heard on Pipeman Radio, Talk 4 Media, iHeartRadio, Pandora, Amazon Music, Audible, Spotify, Apple Podcasts, and over 100 other podcast outlets where you listen to Podcasts.The following are the different podcasts to Follow, Listen, Download, Subscribe:The Adventures of PipemanPipeman RadioPipeman in the Pit – Music Interviews & FestivalsPipeman – The Wandering JewPositively Pipeman – Empowerment, Inspiration, Motivation, Self-Help, Business, Spiritual & Health & WellnessClick Here to Subscribe for PERKS, BONUS Content & FREE GIVEWAYS!Follow @pipemanradio on all socials & Pipeman Radio Requests & Info at www.linktr.ee/pipemanradioStream The Adventures of Pipeman daily & live Mondays, Tuesdays, Wednesdays at 1PM ET on W4CY Radio & Talk 4 TV. Download, Rate & Review the Podcast at The Adventures of Pipeman, Pipeman Radio, Talk 4 Media, iHeartRadio, Apple Podcasts, YouTube & All Podcast Apps.

06/21/2026The Healthy Matters PodcastS06_E01 - High Temps, Higher Stakes - Medications and Substances vs. The Summer HeatWith Special Guest: Brit Culp, ADCT, CPP Summer is finally here, and with it, the HEAT - and yes, the PARTIES!  Whether it's a bar night out, a concert, a festival, or a PRIDE event, the heat can have a big impact on how much fun we can have, and the ill effects can oftentimes be compounded by the prescription drugs, recreational drugs and alcoholic and caffeinated beverages that might be in our bodies.  But how do these substances amplify the effects of the heat?  Which ones should we be most concerned with?  And what are some of the best practices to "party smart"?Research suggests that as temperatures rise, overdoses do, too, so on Episode 1 of Season 6, we'll be joined by Brit Culp (ADCT, CPP) to go over all of the do's and don'ts of adult summer fun.  We'll cover some of the most concerning medications and substances, how to keep the downsides to a minimum, and why the "Lower and Slower" concept is your friend.  The summer heat is no joke, and it's even less funny when it turns a would-be good night into a trip to the ED.  So join us and get wise on how to have a good time, safely - and happy Pride!Got healthcare questions or ideas for future shows?Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

Opioid overdose deaths are dropping in Canada, but there is still a long way to go. Canada's Fentanyl Czar Kevin Brosseau is fresh back from meeting officials in Washington, he tells The House what worries him most about this public health crisis and why the increasingly small quantity of opioids crossing the border is still an irritant for the Americans. Plus, a special parliamentary committee says Ottawa should 'indefinitely exclude' people whose sole underlying condition is a mental illness from applying for medical assistance in dying — an idea that three Canadian senators vigorously oppose. Kristopher Wells, a member of the Progressive Senate Group, explains why he disagrees with the recommendation. Then we hear from BC Conservative MP Tamara Jansen on why MAID expansion should be stopped. And, if at first you don't succeed with your privacy bill: try, try again. The Liberals' third attempt at updating its privacy laws was tabled earlier this week, which includes a 'right to request deletion' and rules on personal data collection. House producer Derek Vanderwyk explains what's inside this key piece of legislation, then BlackBerry co-founder Jim Balsillie discusses whether it strikes the right balance on upholding Canadians' privacy without stymieing innovation.This episode features the voices of:Kevin Brosseau, Canada's fentanyl czarKristopher Wells, Canadian senatorTamara Jensen, Conservative MPDr. Francois Marquis, deepfake victimDr. Marla Shapiro, deepfake victimTamir Israel, Director of the Privacy, Surveillance & Technology Program at the Canadian Civil Liberties AssociationTeresa Scassa, Canada Research Chair in Information Law and Policy at the University of OttawaTaylor Owen, Beaverbrook Chair in Ethics, Media and Communications at McGill UniversityJim Balsillie, co-founder of BlackBerry

Ibogaine is regularly categorized as a psychedelic — but that label may be misleading in ways that matter. In this micro, James offers a crash course in what ibogaine actually is: where it comes from, how its unusual pharmacology works, what it does to the mind, and why it holds a position in addiction medicine that no other drug on earth can claim. The risk profile is part of the picture too. This is a clip from 'Psychedelics in Research & Practice | James W. Jesso', Adventures Through The Mind Podcast, episode 200 FULL EPISODE Listen on Apple Podcasts Listen on Spotify Watch on YouTube Read the show notes MORE IBOGAINE EPISODES Treating Traumatic Brain Injury with Ibogaine | Dr. Nolan Williams ~ ATTMind 188 Ibogaine Medical Subculture | Jonathan Dickinson ~ ATTMind 003 SUPPORT THE PODCAST

W. Bryan Hubbard, CEO of Americans for Ibogaine and a leading policy advocate, joins I Am Refocused Radio to discuss ibogaine — a powerful, naturally occurring compound showing remarkable potential for interrupting addiction, reducing withdrawal, and promoting neuroplasticity and healing from trauma, PTSD, and brain injuries. With decades of experience reforming public systems — from leading Kentucky's Opioid Abatement Advisory Commission to driving disability policy and mental health initiatives — Bryan is at the forefront of the national movement to bring safe, evidence-based ibogaine therapy to those who need it most. He shares insights from groundbreaking research, state-level policy wins (including Texas' historic $50M investment), veteran stories of transformation, and the science behind this promising treatment. Whether you're impacted by the opioid crisis, supporting veterans and first responders, or exploring innovative paths to recovery and mental wellness, this conversation offers hope, education, and actionable vision for the future of healing. Tune in for a powerful discussion on policy, science, stigma, and real recovery stories. Key Links:Learn more: wbryanhubbard.comAmericans for Ibogaine: americansforibogaine.org#Ibogaine #AddictionRecovery #PTSD #MentalHealth #RefocusedRadio #VeteransHealthBecome a supporter of this podcast: https://www.spreaker.com/podcast/i-am-refocused-radio--2671113/support.Subscribe now at YouTube.com/@RefocusedNetworkThank you for your time. 

Episode 161: Improving the Pediatric Opioid Prescribing Culture by Jay Kumar

SPONSORS: 1) MARS MEN: For a limited time, our listeners get 50% off FOR LIFE, Free Shipping, AND 3 Free Gifts at Mars Men at https://Mengotomars.com JOIN PATREON FOR EARLY UNCENSORED EPISODE RELEASES: https://www.patreon.com/JulianDorey CLIPPERS DISCORD: https://discord.gg/8QmWEKJ3BT (***TIMESTAMPS in description below) ~ Ben Westhoff is an investigative journalist and one of the most respected experts on the fentanyl crisis in America. His 2019 book, Fentanyl, Inc. exposed the entire fentanyl market problem to the mainstream FOLLOW BEN: IG: https://www.instagram.com/ben.westhoff/?hl=en BOOK: https://a.co/d/03cARvfi DOC: https://www.antagonistfilm.com/ FOLLOW JULIAN DOREY YT: https://www.instagram.com/julianddorey/ X: https://x.com/juliandorey JULIAN YT CHANNELS - SUBSCRIBE to Julian Dorey Clips YT: https://www.youtube.com/@juliandoreyclips - SUBSCRIBE to Julian Dorey Daily YT: https://www.youtube.com/@JulianDoreyDaily - SUBSCRIBE to Best of JDP: https://www.youtube.com/@bestofJDP ****TIMESTAMPS**** 00:00 - Fentanyl Inc., Rave Deaths, China Labs 08:50 - Undercover in China, Suspicious Lab Visit, CCP Rebates 22:51 - Capitol Hill Testimony, Fentanyl Analogs, India Precursors 29:55 - Naltrexone, Vivitrol, Addiction Treatment, Methadone Business 39:49 - Psychedelics, Capitalism, Naltrexone Documentary, Dark Web Dealers 49:29 - Fent-Laced Coke, Antagonist, Percy Menzies, Vivitrol Trials 58:18 - AA, Opioids, Alcohol, Compulsive Behaviors, Naltrexone Critics 01:10:32 - Addictive Personalities, Purdue Pharma, Suboxone Pill Mills 01:11:10 - Standard American Diet, Veganism, Factory Farming, New Holocaust 01:23:43 - Factory Farming, Forks Over Knives, Subsidies, Protein Obsession 01:39:29 - McDonald's Subsidies, Vegan Costs, Grocery Prices, Sports Gambling 01:48:14 - Silk Road, Bitcoin, Gold, Dark Web Dealers 01:58:45 - Online Drug Markets, Snowden, FISA, Hip Hop Journalism 02:08:08 - Eazy-E, Cancel Culture, Substack, NuWaubians, MF DOOM 02:21:05 - Afrika Bambaataa, Music Journalism, Kanye, Narratives 02:29:01 - Streaming, West Coast Hip Hop, Jimmy Iovine, Tupac 02:40:53 - Interscope Records Scandals CREDITS: - Host, Editor & Producer: Julian Dorey - COO, Producer & Editor: Alessi Allaman - https://www.youtube.com/@UCyLKzv5fKxGmVQg3cMJJzyQ - In-Studio Producer: Joey Deef - https://www.instagram.com/joeydeef/ Julian Dorey Podcast Episode 434 - Ben Westhoff Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The Visible Voices Podcast, I sit down with Dr. Scott Weiner, emergency physician, associate professor at Harvard Medical School, and founder of system-wide substance use disorder programming.  Dr. Weiner shares the patient cases that set his life's work in motion, including a fatal overdose on Boston Common that changed how he understood both medicine and advocacy.  Scott addresses the troubling gap in opioid education in American schools, the promise of wearable technology for monitoring patients in recovery, and the real reasons overdose deaths are finally starting to decline. Opioid use disorder is not a moral failure — it is a public health crisis. ▶ Subscribe on YouTube @resaelewissmd — new Visible Voices episodes Wednesdays.

Have you ever been told that the thing you need to get better doesn't exist on the NHS but quietly, it does?This week I'm joined by Dr. Simon Erridge, medical doctor, UCL researcher, and one of the UK's leading voices in medical cannabis. Simon has a way of cutting through the stigma and the noise and what he shares isn't about getting high. It's about patients who've tried everything, suffered for years, and finally found relief.What we explore together:What medical cannabis actually is  and why it's nothing like what you probably picture when you hear the word cannabisWhy the UK is one of the highest opioid-prescribing countries in the world, and what that tells us about how we treat chronic painWhat's actually happening in the brain with PTSD and how medical cannabis can help decouple the trauma from the memory itselfThe shocking contamination rates in illicit cannabis, and why the black market route puts people at real riskWho shouldn't use medical cannabis, and the conditions where it's not appropriateThe full range of conditions being treated right now: from migraines, Crohn's disease and MS to anxiety, depression, OCD and cancer-related symptomsIf you or someone you love has been living with chronic pain, PTSD, endometriosis, or any condition that feels like it has no solution this one is for you.Love, Sarah Ann

Mehul V. Raval, MD, MS, shares how an enhanced recovery protocol improved postsurgical outcomes for children.

CMS continues to pull on the levers it has at its disposal to rein in national healthcare spend, including rulemaking around Medicare Advantage. In April, CMS announced the final rate for MA plans for CY2027, after a controversial proposed rule generated animated pushback — and a fair bit of panic — among payers. In this episode, host Abby Burns speaks with Alex Balmes, Vice President of Actuarial Services at Optum, to unpack what did — and didn't — end up in the final rate announcement, and what that signals for the future of the Medicare Advantage program. Together, they explore the components of the final rate that are most important for payers and providers to pay attention to, respectively, and why. Also in the 2027 final announcement, but not discussed in this episode: four measures are being added or updated in Star ratings calculations (Colorectal Cancer Screening; Care for Older Adults – Functional Status Assessment; Concurrent Use of Opioids and Benzodiazepines (COB); Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)) and three are being removed (Care for Older Adults – Pain Assessment, Medication Reconciliation Post-Discharge, Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR)) We're here to help: Read the 2027 CMS Announcement | 2027 | CMS Episode | 286: A Medicare Advantage reset — and what comes next Ready-to-Use Slides | Medicare Advantage market outlook Stay informed | Healthcare policy updates Tool | Policy Scenario Impact Calculator Connect with an Optum Advisory expert | Optum Learn more about Advisory Board's 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

The damage caused by alcohol costs Americans billions of dollars, and it largely goes unnoticed. Isabella Cueto, chronic disease reporter for Stat, joins host Krys Boyd to discuss the harms of alcohol from elevated cancer risk to liver damage to its impact on violent crime and why public health officials don't seem to have a cohesive strategy to combat its very real consequences. Her series, written with Lev Facher, is “The Deadliest Drug.” Learn about your ad choices: dovetail.prx.org/ad-choices

Scott Kaufman, the Community Initiatives Supervisor, and Jarrett Burton, Coordinator of the Dupage Recovery Oriented System of Care (ROSC), speak with Lisa to discuss the launch of the Dupage Naloxone Program. They highlight the initiative designed to distribute and make available Opioid-related overdose medication to schools, libraries, emergency services, and residents of Illinois.

War is erupting again in the Middle East tonight. For the first time since a fragile ceasefire was enacted in April, Iran launched a direct attack on Israel. It comes in response to Israel's continued strikes on Lebanon's capital. Israel has vowed retaliation. But U.S. President Donald Trump still maintains that a peace deal is close to fruition.Also: Opioid overdoses are skyrocketing in Winnipeg. A CBC data analysis shows the Winnipeg Fire Paramedic Service has responded to more than 2-thousand opioid calls so far this year. Manitoba's government has announced one million dollard to address the toxic drug crisis. You'll hear more about what the province is up against. And: The FIFA World Cup will begin this week. As the event draws more attention to soccer, Canadian officials think it's a good time to pitch a big project to secure long term support for this country's players. Plus: Canada's new Governor General, Undocumented farmworkers fear deportation in California, and more

June 5, 2026 - We examine the top line spending on combatting the opioid epidemic in the recently adopted state budget with Rob Kent, former general counsel at the state Office of Addiction Services and Supports. We also consider regulatory reform to improve the state's capacity.

We are excited to have Joyce Fetrow, project director of the North Michigan Opioid Response Consortium, join us on today's episode of Rural Health Today. Opioid use continues to be prevalent in rural communities, especially those lacking the resources to address it with sustainable solutions. Joyce is here to share her perspective as a leader in the field of opioid response. We'll talk about effective programming, prevention methods, and of course, what it all has to do with rural health.  Follow Rural Health Today on social media! https://x.com/RuralHealthPod https://www.youtube.com/@ruralhealthtoday7665  Follow Hillsdale Hospital on social media! https://www.facebook.com/hillsdalehospital/ https://www.twitter.com/hillsdalehosp/ https://www.linkedin.com/company/hillsdale-community-health-center/ https://www.instagram.com/hillsdalehospital/  Follow our guest! https://www.linkedin.com/in/joyce-fetrow-cprm-cprm-m-chw-87473914b/ https://www.linkedin.com/company/michigan-center-for-rural-health/

Both animals and people can overdose on opioids, like fentanyl or heroine. Dogs —…

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl probe the facts beneath healthcare's biggest headlines. Today's show examines the accelerating progress of generative AI, the political turmoil inside America's leading health agencies and the infectious disease threats testing the nation's public health readiness. The conversation opens with a listener question about how close generative AI is to matching clinicians. Dr. Pearl explains that the technology is advancing faster than he predicted in ChatGPT, MD, with recent research showing an OpenAI model outperforming experienced physicians on emergency room triage and management in text-based clinical cases. He cautions that medicine is more complicated than written scenarios but argues that the trajectory is clear: before today's incoming medical students finish training, generative AI tools are likely to be used in emergency rooms across the country From there, the episode turns to the resignation of former FDA commissioner and Dr. Marty Makary, a two-time Fixing Healthcare guest. Pearl describes Makary as a respected clinician and patient-safety expert who found himself caught between scientific rigor, political pressure, industry opposition and public health critics. His departure, along with other leadership upheaval at FDA, CDC, NIH and HHS, raises a larger concern about whether America's once-trusted scientific agencies can regain their independence and credibility. Here are the other major storylines from episode 107: RFK Jr. removes preventive-care leaders. Pearl criticizes the firing of two respected co-chairs of the U.S. Preventive Services Task Force, warning that prevention policy may be pushed away from scientific evidence. The surgeon general nomination moving toward confirmation. Nicole Safier appears more confirmable than Dr. Casey Means because her vaccine views are closer to the scientific mainstream. A hantavirus outbreak raises public health concerns. A cruise ship outbreak involving the Andes virus appears to have spread person-to-person, causing at least 13 cases, several severe illnesses and three deaths. The U.S. remains vulnerable to fast-moving outbreaks. Pearl says the slow federal response to hantavirus shows how weakened public health capacity could become dangerous if a highly lethal virus were also easily transmissible. Tick bites are rising sharply. ER visits related to tick bites have climbed well above typical levels, driven in part by warmer temperatures and the spread of deer ticks into the Midwest and South. Ebola exposes the cost of global health cuts. A new Ebola strain in the Democratic Republic of Congo has no vaccine or effective treatment, and the outbreak was recognized only after spreading for weeks. USAID and WHO cuts increase risk to Americans. Pearl argues that reducing global public health support does not put “America first” because viruses ignore national borders. Patients should be more concerned when doctors avoid AI entirely. Pearl says he would worry more about clinicians who refuse to use reliable generative AI tools than those who consult them regularly. Opioid overdose deaths are falling but remain devastating. New CDC data show overdose deaths down for the third straight year, but annual fatalities still total roughly 70,000, with overdoses remaining the leading cause of death among adults ages 18 to 44. Vaccine safety data are being suppressed. Pearl closes by describing blocked FDA and CDC research showing COVID and shingles vaccines to be safe and effective, warning that political censorship undermines trust and harms patients. Tune in for more fact-based analysis and practical perspective on the healthcare policies, technologies and trends shaping medicine today. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #107: How politics is weakening America's public health defenses appeared first on Fixing Healthcare.

Episode SummaryNancy Deyo is a former Silicon Valley CEO, Stanford Distinguished Careers Institute Fellow, and author of the forthcoming memoir Perilous Ascent. After a medical crisis on Mount Kilimanjaro, Nancy entered a fifteen-year journey through misdiagnosis, chronic pain, opioid dependence, and identity collapse.In this episode of Stories from Real Life, Nancy shares how the strategies that once defined her success—discipline, endurance, ambition, and pushing through—eventually had to be reexamined. Her story is not about a simple cure or a clean comeback. It is about learning to live differently when life no longer responds to effort in the same way.This conversation explores chronic pain, medical uncertainty, high-performance culture, shame, adaptation, and the deeper meaning of resilience.In This Episode, We Discuss* The medical crisis Nancy experienced on Mount Kilimanjaro* How chronic pain reshaped her identity and daily life* The long road through misdiagnosis and medical uncertainty* Opioid dependence in the context of chronic pain* The emotional cost of high-performance culture* Why “pushing through” can sometimes become harmful* Attending graduate school while unable to sit* Rebuilding a meaningful life without pretending everything is fixed* Her forthcoming memoir, Perilous Ascent* A more honest definition of resilienceMemorable ThemesOne of the most powerful ideas in this conversation is that resilience does not always mean pushing harder. Sometimes resilience means recognizing limits, grieving the life that changed, and adapting with honesty rather than force.Nancy's story will resonate with anyone living with chronic illness, navigating burnout, facing medical uncertainty, caregiving for someone in pain, or rebuilding after a major life disruption.About Nancy DeyoNancy Deyo is a former Silicon Valley CEO and Stanford Distinguished Careers Institute Fellow. Her forthcoming memoir, Perilous Ascent, reflects on a fifteen-year journey through chronic pain, misdiagnosis, opioid dependence, and personal transformation after a medical crisis on Mount Kilimanjaro.Through her writing and speaking, Nancy offers a candid look at what it means to live inside pain, question old definitions of strength, and find a new way forward.Connect with NancyRead Nancy's Substack: Life Inside Pain with Nancy DeyoMedia Well Done, LLC Get full access to Melvin E. Edwards at storiesfromreallife.substack.com/subscribe

A retrospective comparison of two state-funded smartphone-based contingency management programs with different incentives  Drug and Alcohol Dependence This retrospective study compared outcomes for patients with stimulant use disorder enrolled in a smartphone-based contingency management program based on the amount of total incentives possible, either $75 (“low-value”) or $599 (“moderate-value”). The low-value program was based in New Jersey, funded through SAMHSA (which limited reimbursement to $75/patient at the time of implementation, which has since been increased), and rewarded completing drug testing, attending counseling visits, and completing CBT modules rather than abstinence over 16 weeks. The moderate-value program was funded by West Virginia's Medicaid managed care organizations, lasted up to 26 weeks, and largely rewarded negative drug screening results, with additional rewards for counseling and CBT modules. Patients in the moderate-value program submitted significantly higher rates of negative substance tests (36%, with an average of 3.2 negative tests) compared to those in the low-value group (24.7%, with an average of 24.8 negative tests).   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

This week: Embarrassing drunken antics, gig dramas, perfect pitch, heapmaxxing, dude rooms, McCann's wrestling events, stranger encounters, Action Bronson at Katz Deli, analogue banking, tour shows review, Philly cheesesteaks, Miles Davis autobiography, Opioids, Comedy Cellar anxiety, slip & slides, throat lumps, twisted yoga & much more!Sign up to Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for access to exclusive episodes out every Thursday & our brand new merch.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/TheBombSquadPod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SSE ARENA '26 Tickets.⁠⁠⁠⁠⁠⁠⁠MERCH: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bombsquadpod.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow @TheBombSquadPod on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Hosted by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Colin Geddis⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ &⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aaron McCann⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Produced & Edited by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Niall Fegan⁠

Send us Fan MailOne infant is diagnosed with neonatal opioid withdrawal syndrome every 27 minutes, and rates are rising. In this episode of Journal Club, Ben and Daphna review the Optimized NOW randomized clinical trial, a landmark multicenter study published in JAMA. The trial compared symptom-based dosing,  a single opioid dose given when a withdrawal threshold is met against the traditional scheduled opioid taper in infants managed with Eat Sleep Console. The results are striking: symptom-based dosing reduced time to medical readiness for discharge by nearly two and a half days, and 65% of pharmacologically treated infants avoided scheduled opioid dosing entirely. Could this be the evidence-based approach that finally reshapes how we treat NOWS pharmacologically?----Symptom-Based Dosing for Neonatal Opioid Withdrawal: The OPTimize NOW Randomized Clinical Trial. Devlin LA et al HEAL Evaluation of Limited Pharmacotherapies for Neonatal Opioid Withdrawal Syndrome (HELP for NOWS) Consortium.JAMA. 2026 Apr 25:e265782. doi: 10.1001/jama.2026.5782. Online ahead of print. PMID: 42033722Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

  Purpose of the episode: Jeff Krajnak, a combat veteran, shares how medical cannabis helped him reduce opioid dependency and how THC metabolite laws led to criminal charges despite no impairment. Military service with the Navy Seabees and SEAL teams in Iraq and Afghanistan left Jeff with severe PTSD, fibromyalgia, and ankylosing spondylitis, resulting in a medical discharge in December 2013. Post-discharge, Jeff was consuming 11 opioid and psychiatric pills daily, drinking a bottle of vodka a day, and described himself as detached, suicidal, and hospitalized in a psych ward for eight days. Switching to medical cannabis — an indica strain for sleep and a CBD cream for pain — allowed Jeff to reduce from 11 pills to just one, and eventually quit opioids entirely. A 2017 car accident occurred when another driver ran a red light; Jeff and his son were uninjured, he cooperated with police, passed three field sobriety tests, and showed no signs of impairment. Despite every officer on scene testifying he was not impaired, Jeff was arrested 32 days later by a SWAT team due to THC metabolites in his blood — 4 nanograms active, 40 nanograms metabolite — exceeding Nevada's 2-nanogram legal limit. Charges included two felony B counts — felony DUI resulting in death and felony child neglect — carrying a potential 16–20 year prison sentence. Jeff accepted an Alford plea to felony reckless driving and misdemeanor DUI; the judge acknowledged he was not impaired but stated the law left her no choice. Probation terms banned cannabis use, forcing Jeff back onto 22 pills daily — highlighting the legal contradiction that allows high-dose opioid use while prohibiting medical cannabis. Nevada's 2-nanogram THC limit dates to 1999 and is based on a 1986–87 study measuring residual THC in reckless drivers' urine — not impairment — making it scientifically unsound. THC can remain in blood for weeks in chronic users, and up to 90 days depending on testing method and consumption type, meaning the legal limit bears no relationship to actual impairment. Other states apply higher or more flexible standards — California, Washington, and Colorado allow 5 nanograms with rebuttal options, and Michigan does not prosecute medical patients — contrasting sharply with Nevada's near-zero-tolerance approach. Jeff advocates for impairment-based DUI laws rather than residual THC thresholds, arguing that trained Drug Recognition Experts can assess actual impairment without relying on metabolite levels. As president of the Coalition for Patient Rights, Jeff is pushing for federal cannabis de-scheduling — arguing Schedule 3 is insufficient — and working with NORML, MPP, and other organizations to advance legislative reform. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Arizona O'Neill is a Montreal-based writer and illustrator whose work has appeared in numerous magazines and outlets. In her debut graphic novel Opioids and Organs, she takes a deep dive into the history and ethics of organ donation and transplantation. Arizona tells Tom Power about how her father's death and subsequent organ donation a decade ago led her down the path to making this book. She also discusses the creative influence of both her parents and how the process of creating Opioids and Organs helped her process her grief and anger.

James Lasdun explores Murdaugh's claims of opioid addiction and a bizarre staged roadside shooting. He scrutinizes these events as attempts to distract from financial crimes or secure insurance payouts for survivors. (12/16)1920 SPARTANBURG SC

People call methadone a life sentence, a ball and chain. Cato's Dr. Jeffrey Singer talks with Helen Redmond, author of "Liquid Handcuffs," about how a Nixon-era crime control program became America's dominant addiction treatment model, and why it needs to be abolished. Hosted on Acast. See acast.com/privacy for more information.

#938. Ken Rideout has lived a lot of lives—and in this episode, he doesn't hold anything back. From being a full-blown opioid addict for over a decade while secretly building a high-powered Wall Street career… to becoming one of the fastest marathon runners in the world over 50—his story is as intense as it is inspiring.Ken opens up about growing up around addiction, the moment everything shifted after a simple ankle injury, and how he managed to hide it all—even from the people closest to him. He shares what it actually feels like to live a double life, the mental battle of getting sober, and the moment he knew he had to change everything before becoming a father.This is Part 1 of a two-part conversation… and trust me, you're going to want to come back Thursday for Part 2!If you're LOVING this podcast, please follow and leave a rating and review below! PLUS, FOLLOW OUR PODCAST INSTAGRAM HERE!Thank you to our Sponsors! Check out these AMAZING deals!Macy's: Go to macys.com, browse their gift guide, get inspired — and knock it out before Mother's Day sneaks up on you!Figs: Right now, if you go to wearFIGS.com and use the code FIGSRX, you can get 15% off your first order.EPISODE HIGHLIGHTS: (5:15) “One week is all it takes…” the brutal truth about how fast addiction takes over(17:15) It started with just 7 pills… how a simple injury turned into a 10-year addiction.(20:55) He hid his addiction while dating his wife—then she found him unconscious.(33:20) He'd never run an ultramarathon… then won a 155-mile race after just 1 month of training.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Reagan Conrad speaks to Morning Wire on her investigation into the fast-growing kratom and 7-OH epidemic, a cheap gas-station drug that's quietly fueling addiction among thousands of Americans. Get the facts first with Morning Wire.- - -Ep. 2728- - -Wake up with new Morning Wire merch: https://bit.ly/4lIubt3- - -Today's Sponsors:ADF - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.Lean - Get 20% off when you enter code WIRE at https://TakeLean.com- - -Privacy Policy: https://www.dailywire.com/privacymorning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices